1.255
Opko Health Inc (OPK) 最新ニュース
Renaissance Technologies LLC Has $215,000 Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times
Clinical Laboratory Tests Market Top PlayersARUP - openPR.com
Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com
Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN
Marshall Wace LLP Has $1.36 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Invesco Ltd. Has $2.29 Million Stake in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Piper Sandler Keeps Their Buy Rating on Opko Health (OPK) - The Globe and Mail
OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript - Insider Monkey
Weekly CEO Buys Highlight - GuruFocus
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Update - MarketBeat
OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Yahoo Finance
Quote - OPKO Health, Inc.
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast By Investing.com - Investing.com South Africa
OPKO Health Reports Q1 2025 Financial Highlights - TipRanks
OPKO Health: Q1 Earnings Snapshot - MySA
OPKO Health Inc Q1 2025 Earnings: EPS Misses at -$0.10, Revenue Falls Short at $149.9 Million - GuruFocus
OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com
Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com
OPKO Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewswire
OPKO Health Q1: $225M Oncology Asset Sale to Labcorp Plus New Oral GLP-1 Program Launch - Stock Titan
OPKO Health (NASDAQ:OPK) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
OPKO Health (OPK) to Release Earnings on Wednesday - MarketBeat
Pediatric Growth Hormone Deficiency Treatment Market Size - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN
Analyst Expectations For OPKO Health's Future - Benzinga
JPMorgan starts Opko Health stock with Neutral rating By Investing.com - Investing.com India
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga
大文字化:
|
ボリューム (24 時間):